Sun Pharma Acquires Organon in $12 Billion Deal, Largest Takeover by Indian Pharma Company
Sun Pharma is set to acquire Organon in a $12 billion deal, marking the largest takeover by an Indian pharmaceutical company to date. This acquisition represents a significant milestone for Sun Pharma as it expands its global presence.
The acquisition of Organon by Sun Pharma signifies a strategic move to bolster its portfolio and market reach. The $12 billion deal underscores Sun Pharma’s commitment to growth through strategic acquisitions, positioning the company as a major player in the global pharmaceutical landscape.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 4, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10







